Patent · US Active

Methods and pharmaceutical compositions for treatment of cystic fibrosis

US9402821B2 · kind B2 · utility

0Cited by
0References
2Claims
0Family size

Assignees

Inventors

Key dates

Filing dateAug 13, 2013
Grant dateAug 2, 2016
Priority date
Expiry dateAug 13, 2033

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P29/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to a method and compositions for the treatment of cystic fibrosis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.